Sriramulu Elluru

Sriramulu Elluru

Auto-generated profile, based on publicly available information

Sriramulu Elluru

Department of Biomedical & Clinical Sciences, Division of Pediatrics, Linköping University, SE 58185 Linköping, Sweden

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2009 in Nature
Verified
Journal Article
Closed access
PDF file
VAVishukumar AIMANIANDA
Vishukumar AIMANIANDA
Jagadeesh BAYRYJagadeesh BAYRY
Jagadeesh BAYRY
SBSilvia Bozza
Silvia Bozza
OKOlaf Kniemeyer
Olaf Kniemeyer
KPKatia Perruccio
Katia Perruccio
JLJean-Paul Latgé
Jean-Paul Latgé

15 January 2008 in Blood
Verified
Journal Article
Open access
PDF file
AEAmal Ephrem
Amal Ephrem
SCSouleima Chamat
Souleima Chamat
CMCatherine Miquel
Catherine Miquel
SFSylvain Fisson
Sylvain Fisson
LMLuc Mouthon
Luc Mouthon
NMNamita Misra
Namita Misra
The clinical use of intravenous immunoglobulin (IVIg) based on its immunomodulatory and anti-inflammatory potential remains an ongoing challenge. Fcγ receptor-mediated effects of IVIg, although well elucidated in certain pathologies, cannot entirely account for its proven benefit in several autoimmune disorders mediated by autoreactive T cells. In this study, we show that prophylactic infusion of IVIg prevents the development of experimental autoimmune encephalomyelitis (EAE), an accepted animal model for multiple sclerosis (MS). The protection was associated with peripheral increase in CD4+CD25+Foxp3+ regulatory T cell (Treg) numbers and function. The protection was Treg-mediated because IVIg failed to protect against EAE in mice that were depleted of the Treg population. Rather than inducing de novo generation from conventional T cells, IVIg had a direct effect on proliferation of natural Treg. In conclusion, our results highlight a novel mechanism of action of IVIg and provide a rationale to test the use of IVIg as an immunomodulatory tool to enhance Treg in early onset MS and other autoimmune and inflammatory conditions.

11 March 2007 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
VNVir-Singh Negi
Vir-Singh Negi
SESriramulu Elluru
Sriramulu Elluru
SSSophie Sibéril
Sophie Sibéril
SGStéphanie Graff-Dubois
Stéphanie Graff-Dubois
LMLuc Mouthon
Luc Mouthon
SKSrini V. Kaveri
Srini V. Kaveri

1 April 2010 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
KBKushagra Bansal
Kushagra Bansal
SESri Ramulu Elluru
Sri Ramulu Elluru
YNYeddula Narayana
Yeddula Narayana
RCRashmi Chaturvedi
Rashmi Chaturvedi
SPShripad A Patil
Shripad A Patil
KBKithiganahalli N. Balaji
Kithiganahalli N. Balaji
Mycobacterium tuberculosis, the causative agent of pulmonary tuberculosis, infects one-third of the world’s population. Activation of host immune responses for containment of mycobacterial infections involves participation of innate immune cells, such as dendritic cells (DCs). DCs are sentinels of the immune system and are important for eliciting both primary and secondary immune responses to pathogens. In this context, to understand the molecular pathogenesis of tuberculosis and host response to mycobacteria and to conceive prospective vaccine candidates, it is important to understand how cell wall Ags of M. tuberculosis and, in particular, the proline-glutamic acid_polymorphic guanine-cytosine–rich sequence (PE_PGRS) family of proteins modulate DC maturation and function. In this study, we demonstrate that two cell wall-associated/secretory PE_PGRS proteins, PE_PGRS 17 (Rv0978c) and PE_PGRS 11 (Rv0754), recognize TLR2, induce maturation and activation of human DCs, and enhance the ability of DCs to stimulate CD4+ T cells. We further found that PE_PGRS protein-mediated activation of DCs involves participation of ERK1/2, p38 MAPK, and NF-κB signaling pathways. Priming of human DCs with IFN-γ further augmented PE_PGRS 17 or PE_PGRS 11 Ag-induced DC maturation and secretion of key proinflammatory cytokines. Our results suggest that by activating DCs, PE_PGRS proteins, important mycobacterial cell wall Ags, could potentially contribute in the initiation of innate immune responses during tuberculosis infection and hence regulate the clinical course of tuberculosis.

1 June 2008 in Autoimmunity Reviews
Verified
Journal Article
Closed access
JVJanakiraman Vani
Janakiraman Vani
SESriramulu Elluru
Sriramulu Elluru
VNVir-Singh Negi
Vir-Singh Negi
SLSébastien Lacroix-Desmazes
Sébastien Lacroix-Desmazes
MKMichel D Kazatchkine
Michel D Kazatchkine
SKSrini V Kaveri
Srini V Kaveri

18 November 2014 in Seminars in Immunopathology
Verified
Journal Article
Closed access
PDF file
SESri Ramulu Elluru
Sri Ramulu Elluru
SKSrini Kaveri
Srini Kaveri
Jagadeesh BAYRYJagadeesh BAYRY
Jagadeesh BAYRY